How Fentanyl Changed the Paradigm by Deceiving a New Customer Base

Jul 14, 2022

Welcome to The Opioid Matrix: A Journey Into The Rabbit Hole. In this episode, we take a deep dive into the International Side of the war on drugs.
In our conversation with Michael Brown, Counter-Narcotics Interdiction Business Development Director at Rigaku Analytical Devices, we talk about:
  • A Paradigm Shift due to Fentanyl deception.
  • Michael Gray’s Story – How this new paradigm shift affected him personally.
  • Michael’s efforts to shift the conversation from Addiction to the dangers of one-use fentanyl deaths

Views expressed in this material are opinions of the host and the guest, and do not necessarily reflect the views of Rigaku Analytical Devices.

Listen and subscribe on your favorite podcast player

Apple Podcasts

Spotify

Have an idea for an episode topic or guest? Contact Jen Lynch or Michael Brown on LinkedIn.


Listening on a desktop & can’t see the links? Just search for The Opioid Matrix in your favorite podcast player.

Michael W. Brown is the global director of counter-narcotics technology at Rigaku Analytical Devices. He has a distinguished career spanning more than 32 years as a Special Agent for the Drug Enforcement Administration (DEA). Most recently he was the DEA Headquarters staff coordinator for the Office of Foreign Operations for the Middle East-Europe-Afghanistan-India. Prior to that he served as the country attaché in India and Myanmar providing foreign advisory support for counter narcotic enforcement. He also spent 10 years in Pakistan as a special advisor to the US Embassy on various law enforcement issues. Michael is a graduate of the United States Ranger Training Battalion and has a master’s degree in Interdisciplinary Technology and Management from the University of Eastern Michigan.

Contact Us

Whether you're interested in getting a quote, want a demo, need technical support, or simply have a question, we're here to help.